Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Sep 29;17(9):e0275707. doi: 10.1371/journal.pone.0275707

Retraction: Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma

The PLOS ONE Editors
PMCID: PMC9522206  PMID: 36174047

After an internal investigation of this article [1], the PLOS ONE Editors have reason to believe it was published following a compromised peer review process. The staff editors and the handling editor did not identify these concerns prior to publication.

In light of these concerns, the PLOS ONE Editors retract this article.

HS did not agree with retraction. CH responded but expressed neither agreement nor disagreement with the editorial decision. YL, BL, WY, ZH, GS, RG, CW, LY and YZ either did not respond directly or could not be reached.

Reference


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES